USPH Maintains Outperform by Barrington Research -- Price Target Raised to $98.00

Barrington Research has reiterated its Outperform rating on U.S. Physical Therapy (USPH) while raising the price target to $98.00. This analyst action signals continued positive sentiment toward the publicly traded outpatient physical therapy company's financial outlook.

Read full article at GuruFocus ↗

About this summary. The text above is a short summary written for this site. The original article is hosted by GuruFocus at the link above; this site does not reproduce the full article. Verify against the source before relying on specific details.